Sector: MedicalAmgen Inc. (NASDAQ: AMGN)
Headlines
- Visa (V), Mastercard (MA) versus Walmart (WMT), Target (TGT)
Jun 18, 2015 05:06 PM | AMGN, AXP, BAC, C, JPM, MA
- Enterprise And Retail Speakers Showcasing Their Use Of Video At Streaming Media West
Nov 05, 2009 09:00 AM | AMGN, BAC, FLS, LMT, SWY
- Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
Nov 05, 2009 08:04 AM | AMGN
- Call for Applications: The Amgen Award for Science Teaching Excellence
Nov 04, 2009 12:23 PM | AMGN
- Neuroendocrine Tumours
Nov 03, 2009 12:22 PM | AMGN, AZN, NVS, SNY, TU
- Biosimilars of TNF-alpha Inhibitors Stand to Erode Over $9 Billion in Brand Sales in the U.S. and Europe by 2018
Nov 03, 2009 08:01 AM | AMGN
- Trading Outlook for Avanir Pharmaceuticals Inc. Issued by InvestorSoup.com
Nov 03, 2009 06:51 AM | AMGN, GSK, LLY
- Biotech Takes It on the Chin in October
Nov 02, 2009 12:06 PM | AFFX, AMGN, BIIB, ILMN
- Caliper Life Sciences Presents LabChip(R) Platform to the U.S. Food and Drug Administration
Nov 02, 2009 11:02 AM | AMGN, BIIB, CALP, PFE
- Stock-PR.com Announces Daily Stock Watch: NVAX, HGSI, AMGN
Nov 02, 2009 09:40 AM | AMGN, HGSI, NVAX
- State AGs suing U.S. drug maker Amgen
Oct 31, 2009 04:35 PM | ABC, AMGN
- Business Highlights
Oct 30, 2009 06:53 PM | AMGN, CIT
- The Business Diary
Oct 19, 2009 01:55 AM | AMGN, BA, FRX, LLY, MTB, NTRS
- Stock Market, Economy Heading Back to 'Normal'
Sep 30, 2009 12:57 PM | AMGN, APC, COP, NOV, UNH, WYE
- Stock Market, Economy Heading Back to 'Normal'
Sep 30, 2009 05:55 AM | AMGN, APC, BLK, COP, IBM, LEH
- Consultant Delivers Report on R.I. Economy
Sep 10, 2009 09:57 AM | AMGN
- Partial approval for Amgen bone drug
Aug 14, 2009 12:09 PM | AMGN
- Business Highlights
Aug 13, 2009 06:56 PM | AMGN, CIT, F, WMT
- Business Highlights
Aug 11, 2009 05:54 PM | AMGN, C, WYE
- Healthcare Industries Spending Millions on Lobbying to Influence Lawmakers
Jul 31, 2009 07:50 AM | AMGN, LLY, PFE
- Cytokinetics Announces Addition to Board of Directors
Nov 06, 2009 07:51 AM | AMGN, ARQL, CYTK
- NPS Pharmaceuticals Reports Third Quarter Results and Improved Cash Burn Guidance
Nov 04, 2009 04:53 PM | AMGN, NPSP
- SaaS Leader Daptiv Adds Amdocs and Microsoft Veteran Chase Franklin As CEO
Sep 21, 2009 12:57 PM | AMGN, MSFT
- GENova Biotherapeutics (GVBP) SqueezeTrigger Price is $0.43. Approximately 57 Million Shares Shorted Since July 2009 According to Buyins.Net Research Report
Sep 17, 2009 04:12 AM | AMGN, PFE
- Symyx Joins SAFE-BioPharma to Ensure Safe Security Standards for ELN Software; Pharmaceutical Industry Non-Profit Maintains Standards and Certification for Digital Signatures
Sep 15, 2009 04:52 PM | AMGN, AZN, JNJ, LLY, PFE, SMMX
- Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
Aug 25, 2009 04:13 PM | AMGN
- Fusing Science and Society: Media Entrepreneur Adam Bly Launches National Biotechnology Week in London, Ontario
Aug 25, 2009 10:54 AM | AMGN, PFE
- BenchmarkJournal.Com Free Analyst Review for HCBK, PLCE, GNTX, AMGN, NPBC and LAMR
Aug 25, 2009 07:12 AM | AMGN, GNTX, HCBK, LAMR, NPBC, PLCE
- Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer
Aug 17, 2009 05:08 PM | AMGN
- Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
Aug 13, 2009 06:38 PM | AMGN
- Form 4 RICHO ANNA For: Nov 05 (10K)
Nov 06, 2009 08:00 PM
- Form 4 BONANNI FABRIZIO For: Nov 05 (10K)
Nov 06, 2009 07:47 PM
- Form 4 SHARER KEVIN W For: Nov 05 (10K)
Nov 06, 2009 05:50 PM
- Form 4 OMENN GILBERT S For: Sep 28 (10K)
Sep 30, 2009 03:11 PM
- Form 3 HENDERSON REBECCA M For: Jul 09 (10K)
Jul 16, 2009 08:37 PM
- Form 4 AMGEN INC For: Jun 09 Filed by: MORROW GEORGE J (10K)
Jun 10, 2009 04:59 PM
- Form 4 BEIER DAVID W For: Jun 03 (10K)
Jun 05, 2009 02:31 PM
- Form 4 MCNAMEE BRIAN M For: Jun 03 (10K)
Jun 03, 2009 09:21 PM
- Form 4 PERLMUTTER ROGER M For: Jun 02 (10K)
Jun 02, 2009 08:51 PM
- Form 4 RICHO ANNA For: May 22 (10K)
May 22, 2009 07:17 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
AMGN
|
Compare to S&P
|
| YTD |
-7.15 %
|
-19.06 %
|
| 4 Weeks |
-8.47 %
|
-9.44 %
|
| 12 Weeks |
-11.36 %
|
-13.56 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 17.32 %
|
|
EPS Growth in Last Year: 23.14 %
|
|
Sales Growth in Last Quarter: 2.67 %
|
|
Sales Growth in Last Quarter: -1.63 %
|
|
